Food/Drugs/Healthcare/Life Sciences

How to ensure non-NHS health care organisations are prepared for CQC registration

Registering with the Care Quality Commission (CQC) is compulsory for all providers of health and social care in England, not just those as part of the NHS, and it is against the law not to do so. The provider can be an individual, a partnership or an organisation and knowing which of these legal entities… Read More

The EU General Court Endorses the Reasoning of the European Commission in Relation to Reverse Payment Settlements

With the Lundbeck Decision, the European Commission’s (the “Commission” and the “Decision,” respectively) ended its ten-year investigation on reverse payment settlements and found that the Danish pharmaceutical company, Lundbeck, and four generics producers had concluded anticompetitive agreements, in breach of Article 101 of the Treaty on the Functioning of the European Union (the “TFEU”).[2]  According… Read More

Stacking the Deck -Again! Clinical Negligence Litigation Cost.

Back in the early part of 2016 I looked at how changes to the costs rules since April 2013 had benefitted Defendants at the expense of Claimants. I pointed out that many had commented that successive governments had been increasingly pro-Defendant in their reforms. The announcement earlier in 2016 by the then Health Minister, Ben… Read More

Recreational Marijuana's Economic Advantages

As Seattle City Attorney Pete Holmes has famously touted, marijuana prohibition and the war on drugs has failed.[1] Evidence does not suggest that the War on Drugs reduced drug-use rates or drug dependency.[2] At any given time, there are at least 137,000 men or women locked in prison or held in jail on drug possession… Read More

The Fate of Pharma Patents in U.S. Inter Partes Review Proceedings

As part of the 2011 America Invents Act,[1] the United States Congress created a new process for challenging the validity of issued U.S. patents in the Patent Office (before the Patent Trial and Appeal Board –“PTAB”).  Known as an Inter Partes Review (“IPR”), this process allows third parties to pursue a “mini-trial” against the validity… Read More

Older Entries »